UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells

Biochemical Pharmacology

Volumn 81, Issue 1, 2011, Pages 13-23

  Juncker, Tom ^a   Cerella, Claudia ^a   Teiten, Marie Hélène ^a   Morceau, Franck ^a   Schumacher, Marc ^a   Ghelfi, Jenny ^a   Gaascht, François ^a   Schnekenburger, Michael ^a   Henry, Estelle ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Apoptosis; Cancer; Cardenolide; NF B; UNBS1450

Indexed keywords

CARDIAC GLYCOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; PROTEIN BAK; PROTEIN BAX; PROTEIN MCL 1; STEROID; UNBS 1450; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; TRANSACTIVATION;

APOPTOSIS; CARDENOLIDES; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; MOLECULAR STRUCTURE; NEOPLASM PROTEINS;

EID: 78549284246     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.08.025     Document Type: Article

References (31)

1. Mijatovic T., Lefranc F., Van Quaquebeke E., Van Vynckt F., Darro F., Kiss R. UNBS1450: a new hemi-synthetic cardenolide with promising anti-cancer activity. Drug Dev. Res. 2007, 68:164-173.
2. Lefranc F., Mijatovic T., Kondo Y., Sauvage S., Roland I., Debeir O., et al. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008, 62:211-221. (Discussion 21-22).
3. Juncker T., Schumacher M., Dicato M., Diederich M. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. Biochem. Pharmacol. 2009, 78:1-10.
4. Mijatovic T., Mathieu V., Gaussin J.F., De Neve N., Ribaucour F., Van Quaquebeke E., et al. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 2006, 8:402-412.
5. Mijatovic T., De Neve N., Gailly P., Mathieu V., Haibe-Kains B., Bontempi G., et al. Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Mol. Cancer Ther. 2008, 7:1285-1296.
6. Lefranc F., Mijatovic T., Kiss R. The sodium pump could constitute a new target to combat glioblastomas. Bull. Cancer 2008, 95:271-281.
7. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
8. Balkwill F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 2009, 9:361-371.
9. Coppola S., Ghibelli L. GSH extrusion and and the mitochondrial pathway of apoptotic signalling. Biochem. Soc. Trans. 2000, 28:56-61.
10. Duvoix A., Delhalle S., Blasius R., Schnekenburger M., Morceau F., Fougere M., et al. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 2004, 68:1101-1111.
11. Cerella C., Scherer C., Cristofanon S., Henry E., Anwar A., Busch C., et al. Cell cycle arrest in early mitosis and induction of caspase-dependent apoptosis in U937 cells by diallyltetrasulfide (Al2S4). Apoptosis 2009, 14:641-654.
12. Mijatovic T., Op De Beeck A., Van Quaquebeke E., Dewelle J., Darro F., de Launoit Y., et al. The cardenolide UNBS1450 is able to deactivate nuclear factor kappaB-mediated cytoprotective effects in human non-small cell lung cancer cells. Mol. Cancer Ther. 2006, 5:391-399.
13. Daniel P.T., Wieder T., Sturm I., Schulze-Osthoff K. The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia 2001, 15:1022-1032.
14. Kaufmann S.H., Steensma D.P. On the trail of a new therapy for leukemia. Leukemia 2005, 19:2195-2202.
15. Mijatovic T., Roland I., Van Quaquebeke E., Nilsson B., Mathieu A., Van Vynckt F., et al. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J. Pathol. 2007, 212:170-179.
16. Lomonosova E., Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008, 27(Suppl. 1):S2-S19.
17. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735-1738.
18. Arena V., Martini M., Luongo M., Capelli A., Larocca L.M. Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer 2003, 38:91-96.
19. Bouillet P., Strasser A. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 2002, 115:1567-1574.
20. Henson E.S., Gibson E.M., Villanueva J., Bristow N.A., Haney N., Gibson S.B. Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway. J. Cell Biochem. 2003, 89:1177-1192.
21. Taniai M., Grambihler A., Higuchi H., Werneburg N., Bronk S.F., Farrugia D.J., et al. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res. 2004, 64:3517-3524.
22. Zhang X.D., Nguyen T., Thomas W.D., Sanders J.E., Hersey P. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett. 2000, 482:193-199.
23. Kang M.H., Reynolds C.P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 2009, 15:1126-1132.
24. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005, 310:66-67.
25. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006, 25:6680-6684.
26. Reuter S., Eifes S., Dicato M., Aggarwal B.B., Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol. 2008, 76:1340-1351.
27. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
28. Ahn K.S., Sethi G., Aggarwal B.B. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem. Pharmacol. 2008, 75:907-913.
29. Wu Y., Zhou B.P. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br. J. Cancer 2010, 102:639-644.
30. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 36-37.
31. Sethi G., Sung B., Aggarwal B.B. TNF: a master switch for inflammation to cancer. Front. Biosci. 2008, 13:5094-5107.